Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer Letters|September 27, 2017
BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosisSara Fatima Faqar-Uz-Zaman, Ulrike Heinicke, Michael Torsten Meister, et al.JMIR Formative Research|December 11, 2024
Usability Testing of a Digitized Interventional Prehabilitation Tool for Health Care Professionals and Patients Before Major Surgeries: Formative and Summative EvaluationAndreas A Schnitzbauer, Charlotte Detemble, Sara Fatima Faqar-Uz-Zaman, et al.BMJ Open|April 5, 2023
Study protocol for a pilot trial analysing the usability, validity and safety of an interventional health app programme for the structured prehabilitation of patients before major surgical interventions: the PROTEGO MAXIMA trialSara Fatima Faqar-Uz-Zaman, Svenja Sliwinski, Charlotte Detemble, et al.Antibiotics (Basel, Switzerland)|April 29, 2025
A Prospective Analysis of the Burden of Multi-Drug-Resistant Pathogens in Acute Appendicitis and Their Implication for Clinical ManagementFaruk Koca, Sara Fatima Faqar-Uz-Zaman, Claudia Reinheimer, et al.Cancer Gene Therapy|July 13, 2023
Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic targetPatrizia Malkomes, Ilaria Lunger, Elsie Oppermann, et al.JMIR Mhealth and Uhealth|February 10, 2025
Validity, Accuracy, and Safety Assessment of an Aerobic Interval Training Using an App-Based Prehabilitation Program (PROTEGO MAXIMA Trial) Before Major Surgery: Prospective, Interventional Pilot StudySara Fatima Faqar Uz Zaman, Svenja Sliwinski, Lisa Mohr-Wetzel, et al.Patient Safety in Surgery|April 12, 2024
Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot studySvenja Sliwinski, Sara Fatima Faqar-Uz-Zaman, Jan Heil, et al.Frontiers in Surgery|July 12, 2023
A toolbox for a structured risk-based prehabilitation program in major surgical oncologySvenja Sliwinski, Elisabeth Werneburg, Sara Fatima Faqar-Uz-Zaman, et al.Pageof 1